Please login to the form below

Not currently logged in

Charles River ties up with Theorem for non-clinical testing

CROs form strategic alliance in bioanalysis, immunogenicity and immunology

Charles River Laboratories and Theorem Clinical Research have formed a strategic alliance to provide their clients with a new non-clinical testing and analysis service.

The US clinical research organisations' (CRO) alliance covers bioanalysis, immunogenicity and immunology programmes to support trials running all the way up to product registration.

Alan Bartlett, executive director of laboratory services, Charles River Laboratories: “We are pleased to partner with a world-class clinical trials organization like Theorem Clinical Research. Sponsors will benefit from the experience of both organisations. The alliance will offer a seamless transition from preclinical testing into the clinical arena.”

For Theorem the deal caps a busy few months that have seen it look to expand its network by signing a series of strategic alliances. Since July it has tied up with medical product development firm Ximedica, medical imaging company RadMD and regulatory consultancy the Emergo Group.

Article by
Dominic Tyer

17th September 2013

From: Research



Featured jobs

Subscribe to our email news alerts


Add my company
GEM Marketing Ltd

GEM, a small but perfectly formed integrated marketing agency servicing the pharmaceutical industry....

Latest intelligence

Digital health
The untapped potential to transform healthcare...
When is it time to rebrand?
The Biosimilar Challenge